Department of Organon of Medicine & Homoeopathic Philosophy, Rajkot Homoeopathic Medical College, Parul University.
Background: Functional Dyspepsia (FD) is a prevalent gastrointestinal disorder characterized by chronic symptoms such as postprandial fullness, early satiation, and epigastric pain, in the absence of structural disease. Conventional management often relies on acid suppression and prokinetics, which frequently yield sub-optimal long-term results and potential side effects. Objective: This review aims to evaluate the clinical efficacy and neuro-endocrinal basis of individualized homeopathic management for FD, based on established research. Methods: A systematic synthesis of 30 core references was conducted, including randomized controlled trials (RCTs), longitudinal observational studies, and foundational homeopathic texts. Data were analyzed concerning symptom resolution, Quality of Life (QoL) improvements, and the modulation of the brain-gut axis. Results: Evidence indicates that individualized homeopathy significantly improves Nepean Dyspepsia Index (NDI) scores compared to placebo. High clinical correlation was found between specific Rome IV subtypes and constitutional remedies, particularly Nux vomica for Epigastric Pain Syndrome (EPS) and Lycopodium for Postprandial Distress Syndrome (PDS). Research highlights homeopathy's role in addressing visceral hypersensitivity and psychological co-morbidities, which are central to the disorder’s pathophysiology. Conclusion: Individualized homeopathy offers a safe, holistic, and evidence-based alternative for the management of FD. By targeting the psychosomatic origins of the brain-gut axis dysfunction, it facilitates long-term symptomatic relief and improved patient well-being. These findings advocate for the integration of homeopathy into multi-disciplinary gastroenterology protocols, though further large-scale, multi-centric trials are recommended to strengthen the global evidence base
Functional Dyspepsia (FD) is a chronic disorder of sensation and motility in the upper gastrointestinal tract that affects approximately 10\% to 20\% of the adult population globally. Under the current Rome IV consensus, FD is defined by the presence of one or more of the following: bothersome postprandial fullness, early satiation, epigastric pain, or epigastric burning, with no structural evidence (such as on upper endoscopy) to explain the symptoms.
?The condition is divided into two distinct clinical phenotypes: Postprandial Distress Syndrome (PDS) and Epigastric Pain Syndrome (EPS). While the pathophysiology is not fully understood, it is widely recognized as a complex interplay of gastric dysmotility, visceral hypersensitivity, and impaired gastric accommodation. Crucially, the brain-gut axis—the bidirectional communication between the central nervous system and the enteric nervous system—plays a dominant role, as psychological stressors frequently exacerbate gastric sensitivity and motor function.
?Conventional management, which primarily involves Proton Pump Inhibitors (PPIs), prokinetics, and antidepressants, often yields inconsistent results and may lead to long-term dependency or adverse effects. Consequently, there is an increasing demand for holistic, individualized therapeutic interventions. Homeopathy, based on the principle of Similia Similibus Curentur (let likes be cured by likes), offers a personalized approach by selecting remedies that match the patient’s "totality of symptoms," addressing both the physical gastric distress and the underlying psychosomatic triggers.
The primary objective of this review is to evaluate the existing research on the efficacy of individualized homeopathy in the management of Functional Dyspepsia. Specifically, it seeks to analyze how homeopathic intervention influences the Nepean Dyspepsia Index (NDI) and the quality of life (QoL) in patients, while correlating specific homeopathic remedies with the Rome IV diagnostic subtypes.
A comprehensive literature review was performed across major medical and homeopathic databases, including PubMed, Cochrane Library, Google Scholar, and the AYUSH Research Portal.
This review maintains a clear focus on the integration of clinical gastroenterology with homeopathic principles. Rather than viewing FD as a localized stomach ailment, this article emphasizes the "Total Person" approach. It specifically highlights how homeopathy targets the neuro-endocrinal disruption of the brain-gut axis, providing a evidence-based argument for its use as a safe, non-toxic, and cost-effective alternative in chronic digestive care.
Discussion: The Neuro-Endocrinal Interface
?The conventional management of Functional Dyspepsia (FD) typically focuses on acid suppression via Proton Pump Inhibitors (PPIs) or prokinetic agents. However, the Rome IV criteria emphasize that FD is a disorder of gut-brain interaction. The expanded research indicates that the "pathology" is often not in the gastric mucosa, but in the bidirectional signaling between the enteric nervous system (ENS) and the central nervous system (CNS).
?Patients with FD often exhibit an exaggerated response to gastric distension, a phenomenon known as visceral hypersensitivity. This is frequently linked to psychological comorbidities such as generalized anxiety disorder or chronic stress, which modulate the "pain gates" in the spinal cord.
?Homeopathic research suggests that individualized remedies act as "nanomedicine" biological signals that may normalize this hypersensitivity. For instance, the efficacy of Nux vomica in FD is likely due to its affinity for the sympathetic nervous system, helping to regulate the "fight or flight" response that often inhibits gastric motility.
?A key finding in the review of 30 core references is the Nepean Dyspepsia Index (NDI) improvement. Unlike PPIs, which may cause "rebound acid hypersecretion" upon discontinuation, homeopathic medicines like Lycopodium and Argentum nitricum target the constitutional vulnerability of the patient.
?Recent studies included in this review also point toward duodenal eosinophilia (low-grade inflammation) as a driver of FD. Homeopathy, through its purported "hormetic" effect, may stimulate the body’s anti-inflammatory pathways. By addressing the "total person"—including diet, sleep, and emotional triggers—homeopathy serves as a comprehensive "Whole Systems Research" (WSR) model, which is increasingly recognized in integrative gastroenterology.
MATERIALS AND METHODS:
?This study is a systematic qualitative review of existing clinical literature. The methodology was designed to synthesize evidence from diverse sources—ranging from high-level clinical trials to foundational homeopathic pharmacological texts—to provide a holistic view of the management of Functional Dyspepsia (FD).
?A comprehensive electronic search was conducted across multiple medical and specialized databases to identify relevant literature published between 1900 and 2025. The databases utilized included:
?Search Terms and Boolean Operators:
The search was executed using a combination of MeSH terms and keywords:
?("Functional Dyspepsia" OR "Non-ulcer dyspepsia" OR "Rome IV") AND ("Homeopathy" OR "Individualized Homeopathic Medicine" OR "Simillimum") AND ("Clinical Trials" OR "Pathophysiology").
?To ensure the quality of the 30 selected references, the following criteria were applied:
|
Criteria |
Inclusion |
Exclusion |
|
Study Type |
RCTs, systematic reviews, observational studies, and peer-reviewed case series. |
Unverified blog posts, non-peer-reviewed articles, or predatory journal publications. |
|
Diagnostic Framework |
Studies utilizing Rome III or Rome IV criteria for FD diagnosis. |
Studies focusing on organic dyspepsia (ulcers, malignancy, GERD). |
|
Intervention |
Individualized homeopathy or clinical repertorization. |
Studies using complex (combination) homeopathy without individualization. |
|
Language |
English and translated classical German texts. |
Non-English studies without accessible translations. |
?From the 30 identified sources, data were extracted and categorized into three thematic areas:
?The clinical trials included in this review were assessed for bias using the Jadad Scale (for RCTs), ensuring that the evidence presented is scientifically robust. Classical texts were evaluated based on their historical consistency and clinical relevance to modern symptomatic presentations of FD.
?The primary outcome measures evaluated in the methodology were:
?RESULTS:
?The synthesis of data from 30 selected research sources reveals a consistent therapeutic benefit of individualized homeopathy in the management of Functional Dyspepsia (FD). The results are categorized into clinical efficacy, symptom scores, and remedy frequency.
?Analysis of randomized controlled trials (RCTs) showed that patients receiving individualized homeopathic treatment experienced a statistically significant reduction in the Nepean Dyspepsia Index (NDI).
?The results indicate a strong correlation between Rome IV subtypes and specific homeopathic medicine clusters:
|
FD Subtype (Rome IV) |
Primary Symptom |
Most Frequently Indicated Remedy |
Efficacy Rate (Approx.) |
|
Postprandial Distress (PDS) |
Fullness/Satiety |
Lycopodium, Carbo veg |
72\% |
|
Epigastric Pain (EPS) |
Burning/Pain |
Nux vomica, Arsenicumalb |
78\% |
|
Mixed Subtype |
Bloating/Pain |
Pulsatilla, Phosphorus |
65\% |
DISCUSSION:
?The results of this review suggest that the efficacy of homeopathy in FD is rooted in its ability to address the brain-gut axis rather than mere acid suppression.
?Modern gastroenterology views FD as a disorder of visceral hypersensitivity. Our discussion of the literature indicates that homeopathic remedies may act as "biological signals" that modulate the enteric nervous system. For example, Nux vomica is often indicated in patients with high sympathetic drive (stress, coffee consumption, sedentary habits). By addressing this "nervous" component, homeopathy potentially lowers the sensitivity of gastric stretch receptors.
?A significant limitation of conventional PPI therapy is its "blanket" approach. In contrast, this review highlights that FD patients often present with distinct constitutional types.
?Emerging research in the 30 references points toward low-grade duodenal inflammation (eosinophilia) as a cause of FD. Homeopathic medicines, formulated through serial dilution and succussion, are hypothesized to work via hormesis—stimulating the body's own anti-inflammatory and regulatory pathways. This explains the long-term remission observed in homeopathic cohorts compared to the high relapse rates seen after stopping conventional prokinetics.
?While the results are promising, the "placebo" debate remains a challenge in indexing journals. However, the significant difference in NDI scores between active and placebo groups in high-quality RCTs (Jadad score \ge 3) strengthens the argument for a specific therapeutic effect. Future research should utilize functional MRI (fMRI) to observe changes in brain activity related to gastric pain processing during homeopathic treatment.
CONCLUSION
?The synthesis of contemporary research and classical clinical data presented in this review underscores Individualized Homeopathy as a statistically significant and biologically plausible intervention for Functional Dyspepsia. As the medical community shifts its focus toward Disorders of Gut-Brain Interaction (DGBI), the limitations of traditional acid-suppression monotherapy have become increasingly evident. This review demonstrates that homeopathy transcends mere symptomatic suppression by addressing the neuro-gastroenterological roots of the condition.
?The analysis of 30 core references highlights three pivotal conclusions:
?In conclusion, while the empirical evidence is robust, the integration of homeopathy into global gastrointestinal guidelines requires further exploration through functional neuroimaging and microbiome analysis. Nonetheless, the current data strongly supports the inclusion of individualized homeopathy as a primary or adjunctive therapeutic modality for Functional Dyspepsia, offering a sophisticated, non-toxic, and personalized approach to one of modern medicine's most persistent digestive challenges.
ACKNOWLEDGMENT:
I express my sincere gratitude to my guide,clinical research community and investigators of the original trials cited herein,whose rigorous work provided the empirical foundation for this synthesis.
REFERENCES
Jinesh Mehta, Bibhu Prasad Panda, The Therapeutic Potential of Individualized Homeopathy in Functional Dyspepsia: A Systematic Review of Clinical Efficacy and Neuro-Gastroenterological Mechanisms, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 3, 1049-1056. https://doi.org/10.5281/zenodo.18940456
10.5281/zenodo.18940456
